Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled furosemide for transient tachypnoea in neonates
NCT01407848Phase 2Completed
- Sponsor
- University of Cologne
- Start
- Jan 2012
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of furosemide in Transient tachypnoea of the newborn (TTN), sponsored by University of Cologne. Started Jan 2012; status: completed.
02
Drugs
furosemide
03
Conditions
Transient tachypnoea of the newborn (TTN)
Beyond the preview
Go deeper on NCT01407848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01407848.